Home | Sitemap | Contact Us | Login   
Announcements
Title: Caution Statement on “Severe Drug Interaction Between Colchicine and P-Glycoprotein or Strong CYP3A4 Inhibitors” required to be included in the product package insert for Colchicine
Date: 13-Oct-2009
Category: DCA letters
Source/Author: DCA
Description: Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009



Source: www.bpfk.gov.my


[ Back ] [ Print Friendly ]






Copyright © 2009 - 2018 Pharmaceutical Association of Malaysia (PhAMA). All Rights Reserved.
Powered by CORNERSTONE CONTENT MANAGEMENT SYSTEM